Infusion Therapy Market Size, Share & COVID19 Impact Analysis-Europe-2023-2029-MedSuite-Includes: Infusion Pumps, Intravenous Sets, Needless Connectors, Stopcocks & Blood Transfusion Sets
In 2022, the European market for infusion therapy devices achieved a valuation of $1.1 billion. Over the forecast period, it is expected to experience significant growth, reaching a value of at least €1.3 billion by 2029.
This medical market research involved a thorough analysis of 46 infusion therapy companies operating across Europe. Through our comprehensive methodology, we obtained insights into market sizes, unit sales, company market shares, and created accurate forecasts.
The full report suite on the European market for infusion therapy devices comprises six categories: infusion pumps, intravenous (IV) sets, needleless connectors (NLCs), IV filters, stopcocks, and blood transfusion sets. Each category is further segmented based on specific distinguishing factors. The infusion pump market is segmented by the type of infusion performed, including large-volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, electronic ambulatory pumps, and disposable ambulatory pumps. Each pump sub-segment is also further segmented by care setting. The IV set market is segmented based on tubing type, such as pump IV sets, gravity IV sets, secondary IV sets, and IV extension sets. Each type of IV set is also segmented by care setting. The needleless connector market is segmented by displacement type, including negative, positive, neutral, and anti-reflux neutral displacement connectors. Additionally, it is segmented by device type (standalone and integrated) and care setting.
DATA TYPES INCLUDEDUnit Sales, Average Selling Prices, Market Value & Growth Trends
Market Forecasts Until 2029, and Historical Data to 2019
Market Drivers & Limiters for Each Infusion Therapy market
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
COVID19 Impact On the European Infusion Therapy Market
Procedure Numbers
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
INFUSION THERAPY MARKET INSIGHTThe growing elderly population in Europe is a major driver for the infusion therapy device market. With the aging population, there is an increased need for frequent and chronic treatments, leading to a rise in demand for infusion therapy devices. This trend is expected to fuel the growth of both the disposable and capital equipment markets, resulting in an increase in unit sales during the forecast period. The growing need for these devices in chronic treatment settings further contributes to the market's expansion.
Over the past five years, European countries have shown a significant trend towards rapid adoption of needleless connectors in the market. This growing interest can be attributed to the numerous advantages offered by these connectors. One key benefit is the improved patient safety they provide by reducing the risk of needlestick injuries and associated infections. Additionally, needleless connectors enhance convenience and efficiency by enabling easier access and administration of medications, thus reducing the need for multiple needle insertions. These advantages have played a pivotal role in driving the widespread adoption of needleless connectors across Europe.
INFUSION THERAPY MARKET SHARE INSIGHTIn 2022, B. Braun emerged as the leading competitor in the European infusion therapy device market. The company achieved significant revenues in the IV set and infusion pump markets, while also leading the market for stopcocks. B. Braun's ability to offer a comprehensive range of infusion therapy products and cater to diverse consumer needs has contributed to its strong market position. Becton Dickinson secured the second position as a leading competitor in the European infusion therapy device market in 2022. The company was involved in various segments of the market covered in this report and demonstrated particular strength in the needleless connector market. Fresenius Kabi ranked third among the top competitors in the European infusion therapy device market. The company has experienced notable growth attributed to its lower manufacturing costs, enabling hospitals and group purchasing organizations (GPOs) to benefit from lower prices.
RESEARCH REGIONAL COVERAGEThroughout this research series, iData Research has covered several countries in great detail.The countries covered are:
Germany
France
U.K.
Italy
Spain
Benelux (Belgium, Netherlands, and Luxembourg)
Scandinavia (Norway, Finland, Sweden, and Denmark)
Switzerland
Austria
Portugal
SEGMENTS COVEREDPlease note that the analysis of each of the Infusion Therapy market segments can be purchased as separate reports, MedCores.
Infusion Pump Market – MedCore – The market analysis is further broken down by:
Product Type: Large Volume Pumps, Syringe Pumps, Patient-Controlled Analgesia Pumps, Electronic Ambulatory Pumps, and Disposable Ambulatory Pumps;
Care Setting: Acute and Alternate Care Settings.
Intravenous Set Market – MedCore – The market is comprised of the segments broken down by:
Product Type: Tubing Type, Pump Sets, Gravity Sets, Secondary Sets, and Extension Sets;
Care Setting: Acute and Alternate Care Settings
Needleless Connector Market – MedCore – The market is further segmented by:
Displacement Type: Negative, Positive, and Neutral Displacement;
Delivery Type: Standalone and Integrated;
Care Setting: Acute and Alternate Care Settings.
Stopcock Market – MedCore – The in-depth analysis of the Stopcock Market.
Blood Transfusion Set Market – MedCore – The chapter provides an overview of the Blood Transfusion Set market.
IV Filters Market – MedCore